Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)

Market Cap	27.41B -12.2%
Revenue (ttm)	24.84B +3.4%
Net Income	1.76B +9.4%
EPS	1.43 +10.8%
Shares Out	1.21B
PE Ratio	15.81
Forward PE	14.33
Dividend	0.70 (3.06%)
Ex-Dividend Date	Jun 25, 2026

Volume	5,242,924
Open	22.68
Previous Close	22.67
Day's Range	22.32 - 22.69
52-Week Range	17.68 - 26.56
Beta	0.26
Analysts	Buy
Price Target	31.44 (+39.05%)
Earnings Date	Aug 28, 2026

About Yifeng Pharmacy Chain

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operate...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2001
• Employees: 38,953
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603939

Financial Performance

In 2025, Yifeng Pharmacy Chain's revenue was 24.43 billion, an increase of 1.54% compared to the previous year's 24.06 billion. Earnings were 1.68 billion, an increase of 9.81%.

Analyst Summary

According to 16 analysts, the average rating for 603939 stock is "Buy." The 12-month stock price target is ¥31.44, which is an increase of 39.05% from the latest price.

Price Target

¥31.44

(39.05% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error